<p>Table listing the demographic data in the groups. Values in medians and IQ range. (CFI/CFS; Cystic fibrosis, pancreas insufficient/sufficient. HC; Healthy controls).</p><p>* Median (range).</p><p>Demographic data.</p
<p>Demographic data of parents and their patient relative by high and low-IES-R groups.</p
<p>Demographic characteristics and clinical data for the 209 patients in the final analysis group.</...
<p>Demographic details of the participants in the study given as median and interquartile range (25<...
<p>*Median (Range).</p><p>Demographic Data of Patients in Three Clinical Settings.</p
*<p>Values are expressed as median (range) or absolute numbers within the population.</p
<p>Composition of the study population. Data is shown as median (range) unless marked otherwise.</p
Demographic data of the healthy cohort (HC) (n = 122) and Fibromyalgia (FM) (n = 29) cohorts.</p
<p>The distribution (according to length-of-stay and diagnosis group) and the most important demogra...
Δ<p>denotes a significant difference between group 1 and 3. (p<0.05).</p>‡<p>denotes a significant d...
<p>Demographic data on all patients, including patients in group 2 and others.</p
<p>The table shows the demographic data of participants both as a whole group or divided by high/low...
<p>CF—cystic fibrosis, HS—healthy subjects</p><p>Median values and interquartile ranges are presente...
<p>Demographic and biological data of the healthy subjects (n = 300) included in the study.</p
<p>Demographic data of children TBE, adult severe TBE, and adult TBE cohorts.</p
<p>Demographic data on all patients, including patients who were divided into four groups according ...
<p>Demographic data of parents and their patient relative by high and low-IES-R groups.</p
<p>Demographic characteristics and clinical data for the 209 patients in the final analysis group.</...
<p>Demographic details of the participants in the study given as median and interquartile range (25<...
<p>*Median (Range).</p><p>Demographic Data of Patients in Three Clinical Settings.</p
*<p>Values are expressed as median (range) or absolute numbers within the population.</p
<p>Composition of the study population. Data is shown as median (range) unless marked otherwise.</p
Demographic data of the healthy cohort (HC) (n = 122) and Fibromyalgia (FM) (n = 29) cohorts.</p
<p>The distribution (according to length-of-stay and diagnosis group) and the most important demogra...
Δ<p>denotes a significant difference between group 1 and 3. (p<0.05).</p>‡<p>denotes a significant d...
<p>Demographic data on all patients, including patients in group 2 and others.</p
<p>The table shows the demographic data of participants both as a whole group or divided by high/low...
<p>CF—cystic fibrosis, HS—healthy subjects</p><p>Median values and interquartile ranges are presente...
<p>Demographic and biological data of the healthy subjects (n = 300) included in the study.</p
<p>Demographic data of children TBE, adult severe TBE, and adult TBE cohorts.</p
<p>Demographic data on all patients, including patients who were divided into four groups according ...
<p>Demographic data of parents and their patient relative by high and low-IES-R groups.</p
<p>Demographic characteristics and clinical data for the 209 patients in the final analysis group.</...
<p>Demographic details of the participants in the study given as median and interquartile range (25<...
DOI
Add to ORKG